Teratogen responsive signaling pathways in organogenesis stage mouse limbs

Reproductive Toxicology

Volumn 27, Issue 2, 2009, Pages 103-110

  Huang, Chunwei ^a   Hales, Barbara F ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cyclophosphamide; DNA damage response; Gene expression; Hypoxia; Hypoxia inducible factor; Limb bud culture; Organogenesis; Teratogen

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ABELSON KINASE; ABELSON KINASE 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CARRIER PROTEINS AND BINDING PROTEINS; CARRIER PROTEINS AND BINDING PROTEINS SLC30A4; CXCL9 CHEMOKINE; DNA BINDING PROTEIN; DNA DIRECTED DNA POLYMERASE DELTA; EPHRIN RECEPTOR A6; FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR F1A; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN A13; HOMEODOMAIN PROTEIN D10; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYOSIN; MYOSIN IB; NECDIN; NUCLEIC ACID BINDING PROTEIN; NUCLEIC ACID BINDING PROTEIN RAD21; SECRETED FRIZZLED RELATED PROTEIN 2; SMAD1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 12; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG; VIMENTIN; WNT11 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; LIMB; MORPHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE H RAS; ORGANOGENESIS; PEA15 ONCOGENE; TTF1 ONCOGENE;

ANIMALS; CLUSTER ANALYSIS; CYCLOPHOSPHAMIDE; FEMALE; FORELIMB; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; GESTATIONAL AGE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; ONCOGENES; ORGANOGENESIS; PREGNANCY; SIGNAL TRANSDUCTION; TERATOGENS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

MURINAE;

EID: 62549157322     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2009.01.014     Document Type: Article

References (61)

1. National Research Council. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Committee on Developmental Toxicology. Board on Environmental Studies and Toxicology, Commission on Life Sciences. Washington, DC:National Academy Press; 2000. http://www.nap.edu/books/0309070864/html/.
2. Singh A.V., Knudsen K.B., and Knudsen T.B. Computational systems analysis of developmental toxicity: design, development and implementation of a Birth Defects Systems Manager (BDSM). Reprod Toxicol 19 (2005) 421-439
3. Mikheeva S., Barrier M., Little S.A., Beyer R., Mikheev A.M., Kerr M.K., et al. Alterations in gene expression induced in day-9 mouse embryos exposed to hyperthermia (HS) or 4-hydroperoxycyclophosphamide (4CP): analysis using cDNA microarrays. Toxicol Sci 79 (2004) 345-359
4. Dheen S.T., Hao A.J., Fu J., Gopalakrishnakone P., and Ling E.A. Identification of differentially expressed genes in fetal rat forebrain exposed to a teratogen by cDNA microarray analysis. Histol Histopathol 22 (2007) 729-742
5. Aberg A., Westbom L., and Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61 (2001) 85-95
6. Holmes L.B. Teratogen-induced limb defects. Am J Med Genet 112 (2002) 297-303
7. Man L.X., and Chang B. Maternal cigarette smoking during pregnancy increases the risk of having a child with a congenital digital anomaly. Plast Reconstr Surg 117 (2006) 301-308
8. Zhao X., Sun M., Zhao J., Leyva J.A., Zhu H., Yang W., et al. Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome. Am J Hum Genet 80 (2007) 361-371
9. Cohn M.J., and Tickle C. Limbs: a model for pattern formation within the vertebrate body plan. Trends Genet 12 (1996) 253-257
10. Francis-West P., and Tickle C. Limb development. Curr Top Microbiol Immunol 212 (1996) 239-259
11. Zakeri Z.F., and Ahuja H.S. Cell death/apoptosis: normal, chemically induced, and teratogenic effect. Mutat Res 396 (1997) 149-161
12. Zuzarte-Luis V., and Hurle J.M. Programmed cell death in the embryonic vertebrate limb. Semin Cell Dev Biol 16 (2005) 261-269
13. Lee G.S., Kochhar D.M., and Collins M.D. Retinoid-induced limb malformations. Curr Pharm Des 10 (2004) 2657-2699
14. Ali-Khan S.E., and Hales B.F. Retinoid Receptor Antagonists Alter the Pattern of Apoptosis in Organogenesis Stage Mouse Limbs. Toxicol Sci 90 (2006) 208-220
15. Ali-Khan S.E., and Hales B.F. Novel retinoid targets in the mouse limb during organogenesis. Toxicol Sci 94 (2006) 139-152
16. Chen C.S., Lin J.T., Goss K.A., He Y.A., Halpert J.R., and Waxman D.J. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics. Mol Pharmacol 65 (2004) 1278-1285
17. Gibson J.E., and Becker B.A. The teratogenicity of cyclophosphamide in mice. Cancer Res 28 (1968) 475-480
18. Hales B.F. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein. Cancer Res 42 (1982) 3016-3021
19. Manson J.M., and Smith C.C. Influence of cyclophosphamide and 4-ketocyclophosphamide on mouse limb development. Teratology 15 (1977) 291-299
20. Huang C., and Hales B.F. Role of caspases in murine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide. Teratology 66 (2002) 288-299
21. Moallem S.A., and Hales B.F. Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. Teratology 52 (1995) 3-14
22. Moallem S.A., and Hales B.F. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development 125 (1998) 3225-3234
23. Kwasigroch T.E., Skalko R.G., and Church J.K. Mouse limb bud development in submerged culture: quantitative assessment of the effects of in vivo exposure to retinoic acid. Teratog Carcinog Mutagen 4 (1984) 311-326
24. Studier F.W. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol 79 (1973) 237-248
25. Goodman F.R. Limb malformations and the human HOX genes. Am J Med Genet 112 (2002) 256-265
26. Yoshida K., and Miki Y. Enabling death by the Abl tyrosine kinase: mechanisms for nuclear shuttling of c-Abl in response to DNA damage. Cell Cycle 4 (2005) 777-779
27. Kurita M., Kuwajima T., Nishimura I., and Yoshikawa K. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis. J Neurosci 26 (2006) 12003-12013
28. Ke Q., and Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70 (2006) 1469-1480
29. Semenza G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8 (1998) 588-594
30. Wilkinson D.G. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2 (2001) 155-164
31. Shaut C.A., Saneyoshi C., Morgan E.A., Knosp W.M., Sexton D.R., and Stadler H.S. HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. Dev Dyn 236 (2007) 951-960
32. Knosp W.M., Scott V., Bachinger H.P., and Stadler H.S. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis. Development 131 (2004) 4581-4592
33. Miao D., Liu H., Plut P., Niu M., Huo R., Goltzman D., et al. Impaired endochondral bone development and osteopenia in Gli2-deficient mice. Exp Cell Res 294 (2004) 210-222
34. Mo R., Freer A.M., Zinyk D.L., Crackower M.A., Michaud J., Heng H.H., et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124 (1997) 113-123
35. Mahlapuu M., Enerback S., and Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development 128 (2001) 2397-2406
36. de la Cruz C.C., Der-Avakian A., Spyropoulos D.D., Tieu D.D., and Carpenter E.M. Targeted disruption of Hoxd9 and Hoxd10 alters locomotor behavior, vertebral identity, and peripheral nervous system development. Dev Biol 216 (1999) 595-610
37. Myers C., Charboneau A., Cheung I., Hanks D., and Boudreau N. Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol 161 (2002) 2099-2109
38. Jain S., Maltepe E., Lu M.M., Simon C., and Bradfield C.A. Expression of ARNT, ARNT2, HIF-1 alpha, HIF-2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 73 (1998) 117-123
39. Compernolle V., Brusselmans K., Franco D., Moorman A., Dewerchin M., Collen D., et al. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res 60 (2003) 569-579
40. Provot S., Zinyk D., Gunes Y., Kathri R., Le Q., Kronenberg H.M., et al. Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177 (2007) 451-464
41. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15 (2001) 2865-2876
42. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., and Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 131 (2004) 2161-2171
43. Weinmaster G., and Kopan R. A garden of Notch-ly delights. Development 133 (2006) 3277-3282
44. Krebs L.T., Iwai N., Nonaka S., Welsh I.C., Lan Y., Jiang R., et al. Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. Genes Dev 17 (2003) 1207-1212
45. Brown N.A., Hoyle C.I., McCarthy A., and Wolpert L. The development of asymmetry: the sidedness of drug-induced limb abnormalities is reversed in situs inversus mice. Development 107 (1989) 637-642
46. Wu J., Iwata F., Grass J.A., Osborne C.S., Elnitski L., Fraser P., et al. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol Cell Biol 25 (2005) 1458-1474
47. Carlson T.R., Yan Y., Wu X., Lam M.T., Tang G.L., Beverly L.J., et al. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A 102 (2005) 9884-9889
48. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., and Israel A. Signalling downstream of activated mammalian Notch. Nature 377 (1995) 355-358
49. Begley T.J. Samson LD Network responses to DNA damaging agents. DNA Repair (Amst) 3 (2004) 1123-1132
50. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., and Ahr H.J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res 575 (2005) 61-84
51. Workman C.T., Mak H.C., McCuine S., Tagne J.B., Agarwal M., Ozier O., et al. A systems approach to mapping DNA damage response pathways. Science 312 (2006) 1054-1059
52. Nagano K., Itagaki C., Izumi T., Nunomura K., Soda Y., Tani K., et al. Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase. Oncogene 25 (2006) 493-502
53. Sedletska Y., Giraud-Panis M.J., and Malinge J.M. Cisplatin is a DNA damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticanc Agents 5 (2005) 251-265
54. Shaul Y., and Ben-Yehoyada M. Role of c-Abl in the DNA damage stress response. Cell Res 15 (2005) 33-35
55. Yoshida K., Yamaguchi T., Natsume T., Kufe D., and Miki Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol 7 (2005) 278-285
56. Konishi Y., and Bonni A. The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J Neurosci 23 (2003) 1649-1658
57. Kablar B., Krastel K., Tajbakhsh S., and Rudnicki M.A. Myf5, MyoD activation define independent myogenic compartments during embryonic development. Dev Biol 258 (2003) 307-318
58. Puri P.L., Bhakta K., Wood L.D., Costanzo A., Zhu J., and Wang J.Y. A myogenic differentiation checkpoint activated by genotoxic stress. Nat Genet 32 (2002) 585-593
59. Rauen K.A. HRAS and the Costello syndrome. Clin Genet 71 (2007) 101-108
60. Schalch P., Patejunas G., Retuerto M., Sarateanu S., Milbrandt J., Thakker G., et al. Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: evidence for a central role in vascular homeostasis. J Thorac Cardiovasc Surg 128 (2004) 595-601
61. Hu C.Y., Yang C.H., Chen W.Y., Huang C.J., Huang H.Y., Chen M.S., et al. Egr1 gene knockdown affects embryonic ocular development in zebrafish. Mol Vis 12 (2006) 1250-1258